These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 6096686

  • 1. Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts.
    Megret F, Fournier JM, Alouf JE.
    Med Microbiol Immunol; 1984; 173(4):225-32. PubMed ID: 6096686
    [Abstract] [Full Text] [Related]

  • 2. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H.
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
    Robinson A, Irons LI.
    Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
    [Abstract] [Full Text] [Related]

  • 4. Comparative biological activities of whole cell pertussis vaccine and a new acellular preparation.
    García-Sánz JA, Ruiz-Puente J, Jiménez-Paredes J, González-Pacheco M, Villalva-Posada H.
    Vaccine; 1985 Mar; 3(1):23-6. PubMed ID: 4039870
    [Abstract] [Full Text] [Related]

  • 5. Biological activities of pertussigen from Bordetella pertussis strains of various agglutinogen types.
    Watanabe M.
    Microbiol Immunol; 1984 Mar; 28(5):509-15. PubMed ID: 6088952
    [Abstract] [Full Text] [Related]

  • 6. Development of a pertussis component vaccine in Japan.
    Sato Y, Kimura M, Fukumi H.
    Lancet; 1984 Jan 21; 1(8369):122-6. PubMed ID: 6140441
    [Abstract] [Full Text] [Related]

  • 7. The concept of pertussis as a toxin-mediated disease.
    Pittman M.
    Pediatr Infect Dis; 1984 Jan 21; 3(5):467-86. PubMed ID: 6093069
    [Abstract] [Full Text] [Related]

  • 8. [The development of a new generation of pertussis vaccine].
    Chuprinina RP, Bychenko BD, Smirnov VD, Maksiutov RV, Eglit IuKh.
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct 21; (10):89-94. PubMed ID: 2075771
    [Abstract] [Full Text] [Related]

  • 9. [Toxic factors of Bordetella pertussis, with special reference to leukocytosis-promoting factor, histamine-sensitizing factor and hemagglutinins (author's transl)].
    Sato Y.
    Tanpakushitsu Kakusan Koso; 1976 Nov 21; Suppl():164-83. PubMed ID: 194282
    [No Abstract] [Full Text] [Related]

  • 10. [An acellular pertussis vaccine based on the natural complex of antigens isolated from the supernatant of a synthetic culture medium].
    Zakharova NS, Remova TN, Bazhanova IG, Ozeretskovskaia MH, Britsina MV, Shmeleva EI, Mertsalova NU, Ermolova EI, Sukhinova EE, Bulk VF, Sirotinskiĭ AV, Poluiianova AG, Sviridov VV, Vartanian IuP.
    Zh Mikrobiol Epidemiol Immunobiol; 1997 Nov 21; (3):67-70. PubMed ID: 9304334
    [Abstract] [Full Text] [Related]

  • 11. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK, Saxena SN, Sharma SB, Ahuja S.
    Dev Biol Stand; 1991 Nov 21; 73():205-22. PubMed ID: 1778314
    [Abstract] [Full Text] [Related]

  • 12. [Acellular pertussis vaccine].
    Zakharova NS, Britsina MV, Mertsalova NU, Bazhanova IG, Ozeretskovskaia MN, Zaĭtsev EM, Poddubikov AV, Semenov BF.
    Zh Mikrobiol Epidemiol Immunobiol; 2008 Nov 21; (1):35-41. PubMed ID: 18368750
    [Abstract] [Full Text] [Related]

  • 13. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA, Robinson A, Irons LI, Morgan CP, Isaacs D.
    Lancet; 1983 Oct 15; 2(8355):878-81. PubMed ID: 6137697
    [Abstract] [Full Text] [Related]

  • 14. Comparison of biological activities of Bordetella pertussis mutants lacking the ability to produce filamentous hemagglutinin with similar activities of other smooth strains.
    Watanabe M, Munoz JJ.
    Microbiol Immunol; 1982 Oct 15; 26(10):965-9. PubMed ID: 6298581
    [No Abstract] [Full Text] [Related]

  • 15. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
    Olander RM, Muotiala A, Parviainen T, Runeberg-Nyman K.
    Ann Sclavo Collana Monogr; 1986 Oct 15; 3(1-2):329-35. PubMed ID: 2892513
    [No Abstract] [Full Text] [Related]

  • 16. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M, Odanaka K, Otsuka N, Kamachi K, Watanabe M.
    Microbiol Immunol; 2016 Sep 15; 60(9):599-608. PubMed ID: 27515393
    [Abstract] [Full Text] [Related]

  • 17. Investigating pertussis toxin and its impact on vaccination.
    Coutte L, Locht C.
    Future Microbiol; 2015 Sep 15; 10(2):241-54. PubMed ID: 25689536
    [Abstract] [Full Text] [Related]

  • 18. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R, Lønnes T, Møgster B, Berdal BP.
    Dev Biol Stand; 1985 Sep 15; 61():353-65. PubMed ID: 2872124
    [Abstract] [Full Text] [Related]

  • 19. [Characteristics of the biological properties of a cell-free pertussis preparation].
    Zakharova NS, Remova TN, Bazhanova IG, Ozeretskovskaia MN, Shmeleva EI.
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun 15; (6):38-43. PubMed ID: 2888247
    [Abstract] [Full Text] [Related]

  • 20. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.
    Kamachi K, Konda T, Arakawa Y.
    Vaccine; 2003 Nov 07; 21(31):4609-15. PubMed ID: 14575775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.